Access Statistics for Anirban Basu

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Choosing Wisely: Evaluating Latent Factor Models in the Presence of a Contaminated Instrumental Variable with Varying Strength 0 0 1 1 1 1 25 25
Comparing 2SLS vs 2SRI for Binary Outcomes and Binary Exposures 0 1 2 48 7 10 20 101
Do For-Profit Hospitals Cream-Skim Patients? Evidence from Inpatient Psychiatric Care in California 0 0 4 14 0 1 12 24
Dynamic Efficiency and Pricing of Innovations with Insurance: The Case for Gene Therapies 0 0 1 5 0 0 2 15
Economics of Individualization in Comparative Effectiveness Research and a Basis for a Patient-Centered Health Care 1 1 1 48 4 7 8 182
Estimating Lifetime or Episode-of-illness Costs 1 1 1 109 1 3 4 288
Estimating Person-Centered Treatment (PeT) Effects Using Instrumental Variables 0 0 0 52 0 0 1 155
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 18 0 1 3 100
Exploring comparative effect heterogeneity with instrumental variables: prehospital intubation and mortality 0 0 0 39 1 3 10 193
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 0 46 0 0 2 161
Generalized Modeling Approaches to Risk Adjustment of Skewed Outcomes Data 0 0 0 290 4 4 4 876
Hidden Figures: Uncovering Quantities Behind Zeros with Econometrics 0 0 1 16 0 0 2 22
Impact of Rural and Urban Hospital Closures on Inpatient Mortality 0 0 0 86 1 3 8 159
Political Polarization, Anticipated Health Insurance Uptake and Individual Mandate: A view from the Washington State 0 0 0 16 0 0 0 37
Price Elasticities of Pharmaceuticals in a Value-Based-Formulary Setting 0 0 0 62 2 5 8 101
Returns to Pharmaceutical Innovation in the Market for Oral Chemotherapy in Response to Insurance Coverage Expansion 0 0 0 50 0 0 1 35
Service-level Selection: Strategic Risk Selection in Medicare Advantage in Response to Risk Adjustment 0 0 0 7 1 1 3 52
The Impact of Comparative Effectiveness Research on Health and Health Care Spending 0 0 0 57 0 0 1 229
The New Prescription Drug Paradox: Pipeline Pressure and Rising Prices 0 0 0 73 2 3 8 108
The Role of Physician Altruism in the Physician-Industry Relationship: Evidence from Linking Experimental and Observational Data 0 0 11 11 2 2 18 18
The Roles of Cognitive and Non-Cognitive Skills in Moderating the Effects of Mixed-Ability Schools on Long-Term Health 0 0 0 42 1 1 1 102
The impact of Medicare Part D on Medicare-Medicaid Dual-eligible Beneficiaries' Prescription Utilization and Expenditures 0 0 0 42 0 1 6 164
Understanding Algorithmic Discrimination in Health Economics Through the Lens of Measurement Errors 0 0 0 21 4 4 4 54
Use of Propensity Scores in Non-Linear Response Models: The Case for Health Care Expenditures 0 0 1 54 0 0 2 219
Use of instrumental variables in the presence of heterogeneity and self-selection: An application in breast cancer patients 0 0 3 484 0 3 9 1,346
Use of propensity scores in non-linear response models: The case for health care expenditures 0 0 1 147 0 3 10 525
Welfare Implications of Learning Through Solicitation versus Diversification in Health Care 0 0 0 36 2 3 3 58
Total Working Papers 2 3 27 1,874 33 59 175 5,349


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
CAN WE MAKE SMART CHOICES BETWEEN OLS AND CONTAMINATED IV METHODS? 0 0 0 3 0 1 1 25
Comparing alternative models: log vs Cox proportional hazard? 0 0 2 148 0 0 5 572
Does Competition under Medicare Prospective Payment Selectively Reduce Expenditures on High-Cost Patients? 0 0 0 0 2 5 7 320
ESTIMATING PERSON‐CENTERED TREATMENT (PeT) EFFECTS USING INSTRUMENTAL VARIABLES: AN APPLICATION TO EVALUATING PROSTATE CANCER TREATMENTS 0 0 0 6 2 3 9 48
Economics of individualization in comparative effectiveness research and a basis for a patient-centered health care 0 0 0 29 1 5 7 250
Erratum: Estimating lifetime or episode‐of‐illness costs under censoring 0 0 0 15 0 1 2 48
Estimating lifetime or episode‐of‐illness costs under censoring 1 1 2 22 2 5 8 86
Extended generalized linear models: Simultaneous estimation of flexible link and variance functions 0 0 1 145 0 1 5 421
Generalized modeling approaches to risk adjustment of skewed outcomes data 0 0 0 143 0 1 2 359
HETEROGENEITY IN ACTION: THE ROLE OF PASSIVE PERSONALIZATION IN COMPARATIVE EFFECTIVENESS RESEARCH 0 0 0 2 0 1 1 25
HIGHLIGHTING DIFFERENCES BETWEEN CONDITIONAL AND UNCONDITIONAL QUANTILE REGRESSION APPROACHES THROUGH AN APPLICATION TO ASSESS MEDICATION ADHERENCE 0 0 1 105 3 4 5 292
Implications of spillover effects within the family for medical cost-effectiveness analysis 0 0 0 72 3 7 9 193
Measuring the Value of Pharmaceuticals in the US Health System 0 0 0 5 0 0 0 14
Person-centered treatment (PeT) effects: Individualized treatment effects using instrumental variables 1 1 3 40 2 3 9 155
Personalized Medicine in the Context of Comparative Effectiveness Research 0 0 0 13 1 1 1 103
Private Manufacturers’ Thresholds to Invest in Comparative Effectiveness Trials 0 0 0 5 1 1 1 48
RESPONSE TO EPSTEIN'S COMMENT ON “HETEROGENEITY IN ACTION” 0 0 0 1 0 0 0 18
Scale of interest versus scale of estimation: comparing alternative estimators for the incremental costs of a comorbidity 0 0 0 52 0 0 0 217
The impact of comparative effectiveness research on health and health care spending 0 0 0 35 0 1 2 276
Two-stage residual inclusion estimation: Addressing endogeneity in health econometric modeling 2 4 11 930 12 27 51 2,743
Welfare implications of learning through solicitation versus diversification in health care 0 0 0 2 0 1 2 36
Total Journal Articles 4 6 20 1,773 29 68 127 6,249


Software Item File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
IVCHECK: Stata module to choose between OLS and contaminated IV 0 0 4 28 1 2 19 245
Total Software Items 0 0 4 28 1 2 19 245


Statistics updated 2025-12-06